1921
Volume 95, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Malarial infection and curable sexually transmitted and reproductive tract infections (STIs/RTIs) are important causes of adverse birth outcomes. Reducing the burden of these infections in pregnancy requires interventions that can be easily integrated into the antenatal care (ANC) package. However, efforts to integrate the control of malarial infection and curable STIs/RTIs in pregnancy have been hampered by a lack of evidence related to their coinfection. Thus, we investigated the prevalence of coinfection among pregnant women of rural Zambia. A prospective cohort study was conducted in Nchelenge District, Zambia, involving 1,086 first ANC attendees. We screened participants for peripheral malarial infection and curable STIs/RTIs (syphilis, , gonorrhea, trichomoniasis, and bacterial vaginosis), and collected relevant sociodemographic data at booking. Factors associated with malarial and STI/RTI coinfection were explored using univariate and multivariate regression models. Among participants with complete results ( = 1,071), 38.7% (95% confidence interval [CI] = 35.7–41.6) were coinfected with malaria parasites and at least one STI/RTI; 18.9% (95% CI = 16.5–21.2) were infected with malaria parasites only; 26.0% (95% CI = 23.5–28.8) were infected with at least one STI/RTI but no malaria parasites, and 16.4% (95% CI = 14.1–18.6) had no infection. Human immunodeficiency virus (HIV)-infected women had a higher risk of being coinfected than HIV-uninfected women (odds ratio [OR] = 3.59 [95% CI = 1.73–7.48], < 0.001). The prevalence of malarial and STI/RTI coinfection was high in this population. An integrated approach to control malarial infection and STIs/RTIs is needed to reduce this dual burden in pregnancy.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0370
2016-11-02
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/95/5/1069.html?itemId=/content/journals/10.4269/ajtmh.16-0370&mimeType=html&fmt=ahah

References

  1. McGregor IA, , 1984. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33: 517525.
  2. Watson-Jones D, Weiss HA, Changalucha JM, Todd J, Gumodoka B, Bulmer J, Balira R, Ross D, Mugeye K, Hayes R, Mabey D, , 2007. Adverse birth outcomes in United Republic of Tanzania–impact and prevention of maternal risk factors. Bull World Health Organ 85: 918.[Crossref]
  3. McGregor IA, Wilson ME, Billewicz WZ, , 1983. Malaria infection of the placenta in The Gambia, west Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg 77: 232244.[Crossref]
  4. Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan D, Flenady V, Froen JF, Qureshi ZU, Calderwood C, Shiekh S, Jassir FB, You D, McClure EM, Mathai M, Cousens S, , 2016. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387: 587603.[Crossref]
  5. Brabin BJ, , 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61: 10051016.
  6. Johnson HL, Ghanem KG, Zenilman JM, Erbelding EJ, , 2011. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm Dis 38: 167171.[Crossref]
  7. Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome, 1989. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery. Am J Epidemiol 129: 12471257.[Crossref]
  8. Blas MM, Canchihuaman FA, Alva IE, Hawes SE, , 2007. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington state. Sex Transm Infect 83: 314318.[Crossref]
  9. Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J, , 2013. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect 89: 672678.[Crossref]
  10. Rours GI, Duijts L, Moll HA, Arends LR, de Groot R, Jaddoe VW, Hofman A, Steegers EA, Mackenbach JP, Ott A, Willemse HF, van der Zwaan EA, Verkooijen RP, Verbrugh HA, , 2011. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 26: 493502.[Crossref]
  11. Elliott B, Brunham RC, Laga M, Piot P, Ndinya-Achola JO, Maitha G, Cheang M, Plummer FA, , 1990. Maternal gonococcal infection as a preventable risk factor for low birth weight. J Infect Dis 161: 531536.[Crossref]
  12. Cotch MF, Pastorek JG, 2nd Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG, , 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24: 353360.[Crossref]
  13. Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, St Louis ME, , 1999. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 181: 656662.[Crossref]
  14. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG, 2nd Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA, for the Vaginal Infections and Prematurity Study Group; , 1995. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333: 17371742.[Crossref]
  15. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N, , 1993. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 169: 175178.[Crossref]
  16. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, Clark L, Pringle G, McCormack WM, , 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 150: 965972.[Crossref]
  17. World Health Organization, 2012. Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). Updated WHO Policy Recommendation (October 2012). Available at: http://www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf?ua=1.
  18. World Health Organization, 2004. A Strategic Framework for Malaria Prevention and Control During Pregnancy in the Africa Region. Brazzaville, Congo: World Health Organization Regional Office for Africa.
  19. van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, ter Kuile FO, , 2013. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Infect Dis 13: 10291042.[Crossref]
  20. Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Shi YP, Magnussen P, Meshnick S, Ter Kuile FO, , 2015. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis 62: 323333.[Crossref]
  21. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO, , 2013. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 309: 594604.[Crossref]
  22. Kuznik A, Habib AG, Manabe YC, Lamorde M, , 2015. Estimating the public health burden associated with adverse pregnancy outcomes resulting from syphilis infection across 43 countries in sub-Saharan Africa. Sex Transm Dis 42: 369375.[Crossref]
  23. World Health Organization, 1991. Management of patients with sexually transmitted diseases. Report of a WHO Study Group. World Health Organ Tech Rep Ser 810: 1103.
  24. Pettifor A, Walsh J, Wilkins V, Raghunathan P, , 2000. How effective is syndromic management of STDs? A review of current studies. Sex Transm Dis 27: 371385.[Crossref]
  25. Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D, , 2012. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa. JAMA 307: 20792086.[Crossref]
  26. Chico RM, Moss WJ, , 2015. Prevention of malaria in pregnancy: a fork in the road? Lancet 386: 24542456.[Crossref]
  27. Chaponda EB, Chandramohan D, Michelo C, Mharakurwa S, Chipeta J, Chico RM, , 2015. High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study. Malar J 14: 380.[Crossref]
  28. Central Statistical Office (CSO), 2011. 2010 Census of Population and Housing. Lusaka, Zambia: Central Statistical Office, 12.
  29. Ministry of Health, 2008. Health Management Information System (HMIS). Lusaka, Zambia: Ministry of Health.
  30. Mercereau-Puijalon O, Fandeur T, Bonnefoy S, Jacquemot C, Sarthou JL, , 1991. A study of the genomic diversity of Plasmodium falciparum in Senegal. 2. Typing by the use of the polymerase chain reaction. Acta Trop 49: 293304.[Crossref]
  31. Roper C, Elhassan IM, Hviid L, Giha H, Richardson W, Babiker H, Satti GM, Theander TG, Arnot DE, , 1996. Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am J Trop Med Hyg 54: 325331.
  32. Nugent RP, Krohn MA, Hillier SL, , 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29: 297301.
  33. Chaudhry U, Saluja D, , 2002. Detection of Neisseria gonorrhoeae by PCR using orf1 gene as target. Sex Transm Infect 78: 72.[Crossref]
  34. Kengne P, Veas F, Vidal N, Rey JL, Cuny G, , 1994. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40: 819831.
  35. Schachter J, , 1997. DFA, EIA, PCR, LCR and other technologies: what tests should be used for diagnosis of Chlamydia infections? Immunol Invest 26: 157161.[Crossref]
  36. World Health Organization, 2016. Maternal, Newborn, Child and Adolescent Health. Available at: http://www.who.int/maternal_child_adolescent/epidemiology/stillbirth/en/. Accessed May 18, 2016.
  37. Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, Buve A, Kanga Z, Ndeki L, Rusizoka M, Ross D, Marealle J, Balira R, Mabey D, Hayes R, , 2002. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 186: 948957.[Crossref]
  38. Lauritsen JM, Bruus M, , 2003–2005. EpiData (version 3.1). A Comprehensive Tool for Validated Entry and Documentation of Data. Odense, Denmark: The EpiData Association.
  39. StataCorp, 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.
  40. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S, , 2005. Socioeconomic status in health research: one size does not fit all. JAMA 294: 28792888.[Crossref]
  41. Central Statistical Office (CSO) [Zambia], Ministry of Health (MOH) [Zambia], ICF International, 2014. Zambia Demographic and Health Survey 2013–14. Rockville, MD: Central Statistical Office, Ministry of Health, and ICF International.
  42. McDermott J, Steketee R, Larsen S, Wirima J, , 1993. Syphilis-associated perinatal and infant mortality in rural Malawi. Bull World Health Organ 71: 773780.
  43. Watson-Jones DCJ, Balthazar G, Weiss H, Rusizoka M, Ndeki L, Whitehouse A, Balira R, Todd J, Ngeleja D, Ross D, Buvé A, Hayes R, Mabey D, , 2002. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186: 940947.[Crossref]
  44. Mabey DC, Sollis KA, Kelly HA, Benzaken AS, Bitarakwate E, Changalucha J, Chen XS, Yin YP, Garcia PJ, Strasser S, Chintu N, Pang T, Terris-Prestholt F, Sweeney S, Peeling RW, , 2012. Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med 9: e1001233.[Crossref]
  45. Rowland M, Bouma M, Ducornez D, Durrani N, Rozendaal J, Schapira A, Sondorp E, , 1996. Pyrethroid-impregnated bed nets for personal protection against malaria for Afghan refugees. Trans R Soc Trop Med Hyg 90: 357361.[Crossref]
  46. Lindblade KA, Mwandama D, Mzilahowa T, Steinhardt L, Gimnig J, Shah M, Bauleni A, Wong J, Wiegand R, Howell P, Zoya J, Chiphwanya J, Mathanga DP, , 2015. A cohort study of the effectiveness of insecticide-treated bed nets to prevent malaria in an area of moderate pyrethroid resistance, Malawi. Malar J 14: 31.[Crossref]
  47. Hokororo A, Kihunrwa A, Hoekstra P, Kalluvya SE, Changalucha JM, Fitzgerald DW, Downs JA, , 2015. High prevalence of sexually transmitted infections in pregnant adolescent girls in Tanzania: a multi-community cross-sectional study. Sex Transm Infect 91: 473478.[Crossref]
  48. Walsh MS, Hope E, Isaia L, Righarts A, Niupulusu T, Temese SV, Iosefa-Siitia L, Auvaa L, Tapelu SA, Motu MF, Edwards C, Wernick M, Huston WM, Suaalii-Sauni T, Hill PC, , 2015. Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study. Trans R Soc Trop Med Hyg 109: 245251.[Crossref]
  49. Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, Umbers AJ, Ndrewei N, Siba P, Li Wai Suen CS, Vallely A, Wapling J, Ryan C, Mueller I, Rogerson SJ, , 2015. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect 91: 194200.[Crossref]
  50. ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, Rogerson SJ, Steketee RW, , 2004. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71: 4154.
  51. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG, , 1996. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55: 4249.
  52. Wasserheit JN, , 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19: 6177.[Crossref]
  53. Kapiga SH, Shao JF, Lwihula GK, Hunter DJ, , 1994. Risk factors for HIV infection among women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr 7: 301309.
  54. Chico RM, Hack BB, Newport MJ, Ngulube E, Chandramohan D, , 2013. On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections. Expert Rev Anti Infect Ther 11: 13031332.[Crossref]
  55. Chico RM, Pittrof R, Greenwood B, Chandramohan D, , 2008. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J 7: 255.[Crossref]
  56. Desai M, Gutman J, L'Lanziva A, Otieno K, Juma E, Kariuki S, Ouma P, Were V, Laserson K, Katana A, Williamson J, ter Kuile FO, , 2015. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet 386: 25072519.[Crossref]
  57. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, , 2016. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 374: 928939.[Crossref]
  58. Gutman J, Mwandama D, Wiegand RE, Abdallah J, Iriemenam NC, Shi YP, Mathanga DP, Skarbinski J, , 2015. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi. Malar J 14: 197.[Crossref]
  59. Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS, Maiga B, Mungai M, Parise ME, Doumbo O, , 2005. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 191: 109116.[Crossref]
  60. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW, , 1998. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59: 813822.
  61. ter Kuile FO, van Eijk AM, Filler SJ, , 2007. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 297: 26032616.[Crossref]
  62. Mwewa D, Michelo C, , 2010. Factors associated with home deliveries in a low income rural setting-observations from Nchelenge district, Zambia. Med J Zambia 37: 234239.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0370
Loading
/content/journals/10.4269/ajtmh.16-0370
Loading

Data & Media loading...

  • Received : 10 May 2016
  • Accepted : 09 Aug 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error